lorazepam has been researched along with Nodding Syndrome in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Nodding Syndrome: Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Symptoms of NS and catatonia seem to overlap." | 6.80 | Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study. ( Akena, D; Dhossche, DM; Idro, R; Kakooza-Mwesige, A; Nalugya, J; Opar, BT, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakooza-Mwesige, A | 1 |
| Dhossche, DM | 1 |
| Idro, R | 1 |
| Akena, D | 1 |
| Nalugya, J | 1 |
| Opar, BT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Catatonia in Ugandan Children With Nodding Syndrome and Effects of Treatment With Lorazepam: A Pilot Study[NCT02462109] | Phase 1 | 16 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lorazepam and Nodding Syndrome
| Article | Year |
|---|---|
Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study.
Topics: Adolescent; Adult; Anticonvulsants; Catatonia; Child; Female; Humans; Lorazepam; Male; Nodding Syndr | 2015 |